Dr. Violaine Rosenstiel-Goidts
© dkfz.de
Dr. Violaine Goidts studied Biology at the University of Namur in Belgium and at the University of Uppsala in Sweden.
She carried out her Diploma thesis in the lab of Prof. Dr. M. Vidal at the Dana Farber Cancer Institute in Boston, during which she participated in the establishment of an RNAiome library for Caenorhabditis elegans and used it to understand the TGFb pathway. During her PhD thesis at the University of Ulm that she started in 2003 in the group of Prof. Dr. H. Hameister, she identified large-scale DNA copy-number differences between human and primate genomes and studied their role in mediating evolutionary rearrangements and received the price for an exceptional thesis from the Medical University of Ulm. Determined to pursue a career in Academia since her time in Boston, she joined the DKFZ as a postdoctoral fellow in 2006 in the Division of Molecular Genetics headed by Prof. Dr. P. Lichter. She was awarded with an intramural stipend, followed by a Research Fellowship from the DFG and a Young Investigator Award from the Medical Faculty of the University of Heidelberg. In 2009 she was selected as a mentee from the Helmholtz-Mentoring-Program dedicated to women who aim to reach a leading position. In 2012 she received a project grant from the Strategic Alliance DKFZ-Bayer Schering Pharma in order to develop new small inhibitor compounds targeting the metabolic regulator PFKFB4, which she had identified as being important for glioblastoma survival.
Dr. Goidts is also a mother of three children and has led the DKFZ Junior Research Group “Brain Tumor Translational Targets” since September 2015, which aims to discover new druggable therapeutic targets or new compounds to treat glioblastoma.